Cargando…

Comparative efficacy and safety of anti-HGF/MET pathway agents plus chemotherapy versus chemotherapy alone as first-line treatment in advanced gastric cancer: a protocol for a systematic review and meta-analysis

INTRODUCTION: Phase I/II clinical trials suggested that the hepatocyte growth factor (HGF)/mesenchymal-epithelial transition (MET) pathway-targeted agents were active in suppression of gastric cancer (GC). Randomised controlled trials (RCTs) were undertaken assessing whether the addition of anti-HGF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Zhiyuan, Cai, Zhaolun, Ma, Qin, Shen, Chaoyong, Yin, Yuan, Yin, Xiaonan, Liu, Chunyu, Chang, Chen, Zhao, Zhou, Mu, Mingchun, Zhang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Gastroenterology and Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712986/ https://www.ncbi.nlm.nih.gov/pubmed/34952869 http://dx.doi.org/10.1136/bmjopen-2021-049575

Ejemplares similares

Open and minimally invasive surgery for gastrointestinal stromal tumours: a systematic review and network meta-analysis protocol
por: Mu, Mingchun, et al.
Publicado: (2022)

Impact of Surgical Margin Status on Survival in Gastric Cancer: A Systematic Review and Meta-Analysis
por: Jiang, Zhiyuan, et al.
Publicado: (2021)

Characteristic analysis of early gastric cancer after Helicobacter pylori eradication: a multicenter retrospective propensity score-matched study
por: Liu, Xinyuan, et al.
Publicado: (2023)

Phenotype characteristics of gastric epithelial mucus in patients with different gastric diseases: from superficial gastritis to gastric cancer
por: Dong, Nannan, et al.
Publicado: (2021)

Changes in gastric mucosal microbiota in gastric carcinogenesis: a systematic review protocol
por: Ji, Ruoyu, et al.
Publicado: (2021)

Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C(3)) study
por: Nagasaka, Takeshi, et al.
Publicado: (2016)

Protocol of a prospective, monocentric phase I/II feasibility study investigating the safety of multimodality treatment with a combination of intraoperative chemotherapy and surgical resection in locally confined or borderline resectable pancreatic cancer: the combiCaRe study
por: Roth, Susanne, et al.
Publicado: (2019)

Observational longitudinal multicentre investigation of acute pancreatitis (GOULASH PLUS): follow-up of the GOULASH study, protocol
por: Mikó, Alexandra, et al.
Publicado: (2019)

Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study
por: Nieuwenburg, Stella A V, et al.
Publicado: (2019)

Clinicopathologic features and prognosis of 71 patients with gastric cancer and disseminated intravascular coagulation
por: Chen, Ling, et al.
Publicado: (2023)

Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer
por: Zhan, Xiao-Yong, et al.
Publicado: (2018)

The diagnostic value of serum insulin-like growth factor binding protein 7 in gastric cancer
por: Liu, Can-Tong, et al.
Publicado: (2023)

Trends in hepatocellular carcinoma research from 2008 to 2017: a bibliometric analysis
por: Miao, Yan, et al.
Publicado: (2018)

A decision tree model to predict liver cirrhosis in hepatocellular carcinoma patients: a retrospective study
por: Zhou, Zheyu, et al.
Publicado: (2023)

Discovery of plasma messenger RNA as novel biomarker for gastric cancer identified through bioinformatics analysis and clinical validation
por: Cao, Wei, et al.
Publicado: (2019)

Analysis of factors contributing to postoperative body weight change in patients with gastric cancer: based on generalized estimation equation
por: Tian, Qiuju, et al.
Publicado: (2020)

Endoscopic submucosal dissection versus endoscopic mucosal resection for patients with early gastric cancer: a meta-analysis
por: Tao, Maogen, et al.
Publicado: (2019)

Development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication
por: Yang, Hang, et al.
Publicado: (2022)

Development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication
por: Mori, Hideki, et al.
Publicado: (2022)

Impact of Helicobacter pylori on the gastric microbiome in patients with chronic gastritis: a systematic review and meta-analysis protocol
por: Cao, Xinyuan, et al.
Publicado: (2023)

Longitudinal outcome monitoring in patients with chronic gastroduodenal symptoms investigated using the Gastric Alimetry system: study protocol
por: Varghese, Chris, et al.
Publicado: (2023)

Investigation of Helicobacter pylori infection among symptomatic children in Hangzhou from 2007 to 2014: a retrospective study with 12,796 cases
por: Shu, Xiaoli, et al.
Publicado: (2017)

Prediction models for the survival in patients with intestinal-type gastric adenocarcinoma: a retrospective cohort study based on the SEER database
por: Hong, Jiawen, et al.
Publicado: (2023)

Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China
por: Zhang, Xiangyan, et al.
Publicado: (2018)

Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study
por: Amin, Neeta B, et al.
Publicado: (2022)

Impact of biological agents and tofacitinib for moderate-to-severe ulcerative colitis on health-related quality of life: a protocol for a network meta-analysis
por: Ma, Xueni, et al.
Publicado: (2021)

Gastric emergencies in older adults: not always the same old story! A tertiary care emergency department observational cohort study
por: Rosa, Fausto, et al.
Publicado: (2022)

Response to letter regarding: development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication
por: Mori, Hideki, et al.
Publicado: (2022)

Awareness of risk factors and warning symptoms and attitude towards gastric cancer screening among the general public in China: a cross-sectional study
por: Liu, Qi, et al.
Publicado: (2019)

Undifferentiated-predominant mixed-type early gastric cancer is more aggressive than pure undifferentiated type: a systematic review and meta-analysis
por: Yang, Peng, et al.
Publicado: (2022)

Epigenetic identification of mitogen-activated protein kinase 10 as a functional tumor suppressor and clinical significance for hepatocellular carcinoma
por: Tang, Liping, et al.
Publicado: (2021)

Diagnostic accuracy of linked colour imaging versus white light imaging for early gastric cancers: a prospective, multicentre, randomized controlled trial study
por: Min, Min, et al.
Publicado: (2022)

Efficacy of quadruple regimen with polaprezinc for gastric Helicobacter pylori infection eradication: protocol for a single-centre, single-blind, non-inferiority, randomised clinical trial
por: Wu, Dingkun, et al.
Publicado: (2020)

Long-term outcomes and clinical safety of expanded indication early gastric cancer treated with endoscopic submucosal dissection versus surgical resection: a meta-analysis
por: Xu, Xing, et al.
Publicado: (2022)

Role of echocardiography in screening for portopulmonary hypertension in liver transplant candidates: a meta-analysis
por: Yin, Xin, et al.
Publicado: (2020)

Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: a Markov model to bridge the gap between scientific evidence and clinical practice
por: Broide, Efrat, et al.
Publicado: (2020)

Unexplained abdominal pain as a driver for inappropriate therapeutics: an audit on the use of intravenous proton pump inhibitors
por: Lai, Pauline Siew Mei, et al.
Publicado: (2014)

Anlotinib combined with SOX regimen (S1 (tegafur, gimeracil and oteracil porassium capsules) + oxaliplatin) in treating stage IV gastric cancer: study protocol for a single-armed and single-centred clinical trial
por: Wang, Juan, et al.
Publicado: (2020)

Mobile health-based remote interaction management intervention for patients with low anterior resection syndrome: study protocol for a randomised controlled trial
por: Li, Hui, et al.
Publicado: (2022)

Surgical resection for patients with recurrent or metastatic gastrointestinal stromal tumors: a protocol for a systematic review and meta-analysis update
por: Cai, Zhaolun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h7rstrtisj5kfnlnme6vtki6en